Synthesis and biological evaluation of α-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture

The development of small molecule inhibitors of the viral protease is of considerable interest for the treatment of emergent flaviviral diseases such as Dengue or West Nile fever. Until today little progress has been made in finding drug-like compounds that inhibit the protease and provide a startin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Steuer, Christian (VerfasserIn) , Gege, Christian (VerfasserIn) , Fischl, Wolfgang (VerfasserIn) , Heinonen, Karl H. (VerfasserIn) , Bartenschlager, Ralf (VerfasserIn) , Klein, Christian D. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 18 May 2011
In: Bioorganic & medicinal chemistry
Year: 2011, Jahrgang: 19, Heft: 13, Pages: 4067-4074
ISSN:1464-3391
DOI:10.1016/j.bmc.2011.05.015
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.bmc.2011.05.015
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0968089611003609
Volltext
Verfasserangaben:Christian Steuer, Christian Gege, Wolfgang Fischl, Karl H. Heinonen, Ralf Bartenschlager, Christian D. Klein
Beschreibung
Zusammenfassung:The development of small molecule inhibitors of the viral protease is of considerable interest for the treatment of emergent flaviviral diseases such as Dengue or West Nile fever. Until today little progress has been made in finding drug-like compounds that inhibit the protease and provide a starting point for lead optimization. We describe here the initial steps of a drug discovery effort that focused on the styryl pharmacophore, combined with a ketoamide function to serve as electrophilic trap for the catalytic serine. This resulted in a fragment-like lead compound with reasonable target affinity and good ligand efficiency, which was extensively modified to explore structure-activity relationships. Selected compounds were cross-tested against the West Nile virus protease and thrombin, indicating that selectivity for one or more flaviviral proteases can be achieved. Finally, the antiviral activity of several protease inhibitors was confirmed in a cell-culture model of Dengue virus replication. The SAR presented here may serve as starting point for further drug discovery efforts with the aim of targeting flaviviral proteases.
Beschreibung:Gesehen am 21.10.2022
Beschreibung:Online Resource
ISSN:1464-3391
DOI:10.1016/j.bmc.2011.05.015